Hostname: page-component-7b7567c8c-w7t8q Total loading time: 0 Render date: 2026-11-18T22:35:12.055Z Has data issue: false hasContentIssue false

The clinical usefulness of guideline-based strategies with and without the role of nonspecific symptoms to predict urinary tract infections in nursing homes: a decision curve analysis

Published online by Cambridge University Press:  01 August 2024

Sacha Kuil*
Affiliation:
Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands
Menno de Jong
Affiliation:
Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands
Caroline Schneeberger
Affiliation:
Amsterdam UMC, University of Amsterdam, Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands
Frank van Leth
Affiliation:
Department of Health Sciences, Vrije Universiteit, Amsterdam, The Netherlands
*
Corresponding author: Sacha Kuil; Email: s.d.kuil@amsterdamumc.nl

Abstract

Objective:

The aim of this study was to assess the clinical value of urinary tract infections (UTIs) guideline algorithms and the role of nonspecific symptoms to support clinical decision-making in nursing home residents.

Design:

In a preplanned secondary analysis of a cross-sectional study including nursing home residents with a presumed UTI, 2 prediction models were used in a decision curve analysis (DCA): (1) guideline-based and (2) extended: nonspecific symptom(s) added to the guideline model. The stringent outcome definition for “true UTIs” included symptom improvement during adequate antimicrobial therapy, based on susceptibility test results. The outcome of a DCA is the Net Benefit to quantify the performance of the prediction models, visualized in a decision curve.

Setting:

Dutch nursing homes (n = 13).

Patients:

Nursing home residents with a presumed UTI.

Results:

Of the 180 residents with a presumed UTI, 43 fulfilled the definition of “true UTI” (23.9%). The Net Benefit of the guideline-based model was low and the corresponding threshold range was small (21%–28%). The extended model improved the prediction of UTIs. However, the clinical usefulness of the extended model was still limited to a small threshold range (10%–28%).

Conclusions:

The clinical usefulness of the current guideline-based algorithm to diagnose UTI in nursing home residents seems limited, and adding nonspecific symptoms does not further improve decision-making due to the small threshold probability. Given the poor performance of the guideline-based model, refinement of the guidelines may be required.

Trial registry:

Dutch trial registry: NTR6467; date of first registration, 25/05/2017.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Figure 1.Flow of eligible UTI cases, number of “true UTIs,” and number of UTIs based on the guideline (n = 85) and extended model (n = 136).AB, antibiotics; RTI, respiratory tract infection; UTI, urinary tract infection.a Single UTIs were included, and of the recurrent cases, a random case for each individual was used.b Multiple missing items required for reference testing can occur within 1 UTI case.c No urine culture result or no info about urine collection method.d No information about symptom improvement at day 5 and day 10.

Figure 1

Table 1.Presence of the criteria to fulfill the composite outcome UTI

Figure 2

Figure 2.Results of the decision curve analysis. Net Benefit (y-axis) for the prediction of UTI as a function of the threshold probability (x-axis), for (1) the guideline-based model: inclusion of only specific urinary symptoms and positive leukocyte or nitrite dipstick results (black dotted line); (2) the extended model: according to current guideline or ≥1 nonspecific symptoms with positive leukocyte or nitrite dipstick test, (red dotted line), compared with the treating all patients (gray line) and treating none (black line). The Net Benefit for the extended model including nonspecific symptoms was higher compared with the guideline-based model, treat all and treat none over the range of 10%–28% (red dashed vertical lines). Treating all patients is the best strategy below the threshold of 10%, and treating none is the best strategy above the threshold of 28% (red dashed vertical lines).UTI, urinary tract infection.

Figure 3

Figure 3.Results of the decision curve analysis. Plot demonstrating the additional detected UTIs without unnecessary antibiotic treatments if the extended model is used rather than the guideline-based model per 100 patients with a presumed UTI, as a function of the risk threshold range 0%–28%.UTI, urinary tract infection.

Figure 4

Table 2.Net Benefits for the guideline-based and extended model to predict urinary tract infections (UTI) at a probability threshold of 20%